CONCENTRATION SERVICE COAGULATION DIAGNOSIS
ANALYZER REAGENTS APPLICATION
Recently, a delegation led by Cai Bingxiang, Director of the Macao Special Administrative Region's Drug Administration, visited Beijing for research and exchange. The delegation focused on key areas such as drug and medical device regulation, the development of inspection and testing systems, and the development of smart regulation, engaging in in-depth discussions and sharing experiences. Mr. Zhou Lixin, Second-Level Inspector of the Beijing Municipal Drug Administration, and relevant department heads also participated in the research.
During the visit, Director Cai Bingxiang and his delegation visited Beijing Succeeder Company for an on-site survey. Mr. Wu Shiming, Chairman of Beijing Succeeder, warmly welcomed the guests.
Accompanied by company leaders, the delegation first visited the corporate culture exhibition hall, where Mr. Zhang, General Manager, provided a detailed overview of Succeeder's development history, core products, market development, and its work in innovation, manufacturing, integration, and service, as well as its future development plans.
The delegation also observed Beijing Succeeder's independently developed SMART series coagulation flow line and SF-9200 FullyAutomated coagulation analyzer. During the visit, Director Cai Bingxiang highly praised the company's emphasis on R&D investment, talent development, and technological innovation.
The delegation then conducted a field visit to the equipment and reagent R&D departments and production workshops. Deputy General Manager Ding detailed the entire process, from raw material procurement, production processes, quality testing, to product packaging and shipment, showcasing Beijing Succeeder's refined and standardized production management. The two sides engaged in pragmatic and fruitful discussions on topics such as production quality management standards, the development of a reference laboratory system, and intelligent traceability management.
This visit not only deepened mutual understanding between Macao SAR and mainland Chinese companies in the field of medical device regulation but also laid a solid foundation for further collaboration in the pharmaceutical and healthcare industries between the two regions.
As an outstanding domestic manufacturer, Beijing Succeeder has thoroughly implemented the important speech of General Secretary Xi Jinping on the development of the biopharmaceutical industry and actively responded to the requirements of the agreement between the National Medical Products Administration and the Macao SAR Government's Secretariat for Social Affairs and Culture. Beijing Succeeder adheres to innovation as its driving force, continuously enhancing its core competitiveness, actively participating in the high-quality development of the national pharmaceutical industry, and contributing further to the high-quality development of the medical industries in both regions.
Business card
Chinese WeChat
English WeChat